Molecules to market: A probabilistic artificial intelligence framework for predicting managed care adoption at the level of drug discovery.

Sharma R

Open source

DOI
10.18553/jmcp.2026.32.9.1122
Published
2026 Sep
Container
Journal of managed care & specialty pharmacy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18553/jmcp.2026.32.9.1122,
  title = {Molecules to market: A probabilistic artificial intelligence framework for predicting managed care adoption at the level of drug discovery.},
  author = {Sharma R},
  year = {2026},
  journal = {Journal of managed care \& specialty pharmacy},
  doi = {10.18553/jmcp.2026.32.9.1122},
  url = {https://doi.org/10.18553/jmcp.2026.32.9.1122}
}

RIS

TY  - JOUR
TI  - Molecules to market: A probabilistic artificial intelligence framework for predicting managed care adoption at the level of drug discovery.
AU  - Sharma R
PY  - 2026
JO  - Journal of managed care & specialty pharmacy
DO  - 10.18553/jmcp.2026.32.9.1122
UR  - https://doi.org/10.18553/jmcp.2026.32.9.1122
ER  - 

APA

R, S. (2026). Molecules to market: A probabilistic artificial intelligence framework for predicting managed care adoption at the level of drug discovery.. Journal of managed care & specialty pharmacy. https://doi.org/10.18553/jmcp.2026.32.9.1122

Source records